HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has been awarded the BSFZ seal from the German Certification Office for Research Allowance
This recognition underscores the company’s significant contributions to pharmaceutical manufacturing innovation and its commitment to advancing healthcare solutions that benefit both industry partners and end-users. The BSFZ seal is awarded to companies that demonstrate excellence in their R&D activities, meeting rigorous criteria that include pursuing novel insights, addressing uncertainties in outcomes, and following systematic, reproducible processes.
Achieving this recognition is a testament to HERMES PHARMA’s ability to develop groundbreaking solutions that meet the evolving needs of the healthcare industry. For more than 40 years, HERMES PHARMA has been at the forefront of developing and producing innovative solutions for oral dosage forms. The company’s strategic research initiatives address pressing industry challenges, including improving patient compliance, tackling formulation complexities, and enhancing sustainability in manufacturing.
Innovation that benefits patients and consumers style
At the core of HERMES PHARMA’s R&D efforts is the belief that pharmaceuticals and supplements should not only be effective but also convenient to take. By combining scientific excellence with practical application, the company creates solutions that prioritize user convenience, helping pharmaceutical companies deliver treatments that fit seamlessly into patients’ and consumers’ lives.
The company’s R&D excellence and dedication to innovation is demonstrated through three key projects:
- Efficient manufacturing of orally disintegrating granules (ODGs): HERMES PHARMA created a manufacturing process that minimizes resources use while producing high-quality, pleasant-tasting ODGs. Designed to be taken without water, ODGs provide a user-friendly option for individuals on-the-go or with swallowing difficulties, for example. The process enhances production efficiency while ensuring exceptional standards of quality and palatability.
- Formulation of effervescent tablets with unstable and poorly soluble active ingredients: By developing new approaches to delivering unstable and poorly soluble active ingredients in effervescent tablet form, the team created more options for pharmaceutical companies to develop effective treatments and supplements while enhancing user convenience. This innovation is particularly valuable for pharmaceutical companies looking to expand their product portfolios with complex drug combinations that were previously difficult to formulate.
- Hot melt coating technology for extended-release dietary supplements: Using hot melt coating technology, HERMES PHARMA developed a novel dietary supplement that provides a delayed release of its ingredients. Through careful development, the resulting solutions offer significant benefits for both manufacturers and end-users, enabling precise control over nutrient release while maintaining user-friendly characteristics.
Commitment to healthcare innovation
“At HERMES PHARMA, innovation isn’t just about developing new technologies — it’s about creating solutions that make a real difference in healthcare delivery,” says Dr. David Kuch, Senior Director Development & Drug Regulatory Affairs at HERMES PHARMA. “Our research initiatives reflect our commitment to advancing pharmaceutical manufacturing while keeping patient needs at the forefront. The BSFZ seal recognition reinforces our position as a trusted partner in developing the next generation of user-friendly medications.”
The BSFZ seal highlights HERMES PHARMA’s contributions to advancing pharmaceutical innovation and the strength of their research and development efforts. By meeting the rigorous criteria for this recognition, the company demonstrates its ability to address complex industry challenges and contribute to Germany’s reputation as a global leader in pharmaceutical R&D. This acknowledgment serves as a testament to HERMES PHARMA’s impactful work in creating solutions that benefit their industry partners, consumer and patients alike.
To learn more about the BSZF Seal